Testing effectiveness (Phase 2)Study completedNCT00171158
What this trial is testing
An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis
Who this might be right for
Philadelphia Chromosome Positive CML
Novartis Pharmaceuticals 260